Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anti-PD1-induced psoriasis: a study of 21 patients.

Literature DB >> 27739129

Anti-PD1-induced psoriasis: a study of 21 patients.

J Bonigen¹, C Raynaud-Donzel², J Hureaux³, N Kramkimel⁴, A Blom⁵, G Jeudy⁶, A-L Breton⁷, T Hubiche⁸, C Bedane⁹, D Legoupil¹⁰, A Pham-Ledard¹¹, J Charles¹², M Pérol¹³, E Gérard¹¹, P Combemale¹⁴, D Bonnet⁵, M-L Sigal¹, E Mahé¹.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2016 PMID： 27739129 DOI： 10.1111/jdv.14011

Source DB: PubMed Journal: J Eur Acad Dermatol Venereol ISSN： 0926-9959 Impact factor: 6.166

Keyword Cloud
Cited

× No keyword cloud information.

45 in total

1. Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management.

Authors: Emily Coleman; Christine Ko; Feng Dai; Mary M Tomayko; Harriet Kluger; Jonathan S Leventhal
Journal: J Am Acad Dermatol Date: 2018-11-03 Impact factor: 11.527

Review 2. Hyperkeratotic Skin Adverse Events Induced by Anticancer Treatments: A Comprehensive Review.

Authors: Maria Vastarella; Gabriella Fabbrocini; Vincent Sibaud
Journal: Drug Saf Date: 2020-05 Impact factor: 5.606

Review 3. Cutaneous toxicities of new treatments for melanoma.

Authors: A Boada; C Carrera; S Segura; H Collgros; P Pasquali; D Bodet; S Puig; J Malvehy
Journal: Clin Transl Oncol Date: 2018-05-24 Impact factor: 3.405

Review 4. Management of the cutaneous adverse effects of antimelanoma therapy.

Authors: Rose Congwei Liu; Germana Consuegra; Pablo Fernández-Peñas
Journal: Melanoma Manag Date: 2017-11-22

Review 5. Checkpoint Inhibitors.

Authors: Lucie Heinzerling; Enrico N de Toni; Georg Schett; Gheorghe Hundorfean; Lisa Zimmer
Journal: Dtsch Arztebl Int Date: 2019-02-22 Impact factor: 5.594

Anti-PD1-induced psoriasis: a study of 21 patients.

1. Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management.

Review 2. Hyperkeratotic Skin Adverse Events Induced by Anticancer Treatments: A Comprehensive Review.

Review 3. Cutaneous toxicities of new treatments for melanoma.

Review 4. Management of the cutaneous adverse effects of antimelanoma therapy.

Review 5. Checkpoint Inhibitors.

Review 6. Cutaneous Adverse Events of Anti-PD-1 Therapy and BRAF Inhibitors.

7. Nivolumab (PD-1 Inhibitor) Induced Exacerbation of Psoriasis.

Review 8. When worlds collide: Th17 and Treg cells in cancer and autoimmunity.

Review 9. Malignancy Risk and Recurrence with Psoriasis and its Treatments: A Concise Update.

Review 10. The role of xenobiotics in triggering psoriasis.